Will take action against sale of Patanjali Covid-19 drug in Rajasthan: Govt

Neither has anyone applied to the state government nor has the state government given any permission in this regard, State Health Minister Raghu Sharma said

patanjali, coronavirus, ramdev
Ramdev with Acharya Balkrishna (right) at the launch of Coronil and Swasari in Haridwar on Tuesday. PHOTO: PTI
Press Trust of India Jaipur
2 min read Last Updated : Jun 25 2020 | 8:56 AM IST

Amid the ongoing controversy over Yoga guru Baba Ramdev's company Patanjali Ayurveda introducing "cure" for coronavirus infection, Rajasthan government on Wednesday clarified that this drug cannot be not used as a medicine in the state without the permission of the Ministry of AYUSH.

Neither has anyone applied to the state government nor has the state government given any permission in this regard, State Health Minister Raghu Sharma said.

He said according to the gazette notification issued by the Government of India in April this year, under the Drugs and Cosmetic Act 1940 and 1945, no ayurvedic medicine can sold as medicine for corona infection during COVID-19 pandemic without the approval of Union Ministry of AYUSH.

Strict action will be taken against the seller as per the rules in case of sale of any drug as a medicine to treat the coronavirus infection, the minister added.

Patanjali Ayurveda, while presenting ''Coronil'' medicine on Tuesday had claimed that it has found a cure for coronavirus infection.

Sharma said compliance of the guidelines of the Union Ministry of Health, Union Ministry of AYUSH and ICMR is being ensured in the treatment of coronavirus infection in the state.

The health minister said no human clinical test of a drug can be done without the permission of the state government and action will be taken against those who mislead the common people by doing ''clinical trials'' without permission.

Referring to the various guidelines of the central government and other regulatory bodies, Sharma said without their compliance, action will be taken against the publicity and sale of any such means to treat the infection.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccinePatanjali AyurvedAyush MinistryRajasthan government

Next Story